Serum lipoprotein phospholipase A2 level has diagnostic value for cognitive impairment in type II diabetes patients with white matter hyperintensity

References

• Ahmed W, Orasanu G, Nehra V, Asatryan L, Rader DJ, Ziouzenkova O, et al. 2006. High-density lipoprotein hydrolysis by endothelial lipase activates PPARalpha: a candidate mechanism for high-density lipoprotein-mediated repression of leukocyte adhesion. Circ Res 98:490–498.
   PubMed Web of Science ®Google Scholar
• American Diabetes A. 2019. 2. Classification and diagnosis of diabetes: standards of Medical Care in diabetes-2019. Diabetes Care. 42:S13–S28.
   PubMed Web of Science ®Google Scholar
• Baktiroglu S, Yanar F, Ozata IH, Oner G, Ercan D. 2016. Arterial disease and vascular access in diabetic patients. J Vasc Access 17(Suppl 1):S69–S71.
   PubMedGoogle Scholar
• Barkovich AJ, Deon S. 2016. Hypomyelinating disorders: An MRI approach. Neurobiol Dis 87:50–58.
   PubMed Web of Science ®Google Scholar
• Benjamin P, Lawrence AJ, Lambert C, Patel B, Chung AW, MacKinnon AD, et al. 2014. Strategic lacunes and their relationship to cognitive impairment in cerebral small vessel disease. NeuroImage Clin. 4:828–837.
   PubMed Web of Science ®Google Scholar
• Berger JS, Ballantyne CM, Davidson MH, Johnson JL, Tarka EA, Lawrence D, et al. 2011. Peripheral artery disease, biomarkers, and darapladib. Am Heart J 161:972–978.
   PubMed Web of Science ®Google Scholar
• Brundel M, Kappelle LJ, Biessels GJ. 2014. Brain imaging in type 2 diabetes. Eur Neuropsychopharmacol 24:1967–1981.
   PubMed Web of Science ®Google Scholar
• Carlquist JF, Muhlestein JB, Anderson JL. 2007. Lipoprotein-associated phospholipase A2: a new biomarker for cardiovascular risk assessment and potential therapeutic target. Expert Rev Mol Diagn 7:511–517.
   PubMed Web of Science ®Google Scholar
• Clare L, Wu YT, Teale JC, MacLeod C, Matthews F, Brayne C, et al. 2017. Potentially modifiable lifestyle factors, cognitive reserve, and cognitive function in later life: A cross-sectional study. PLoS Med 14:1–14.
   Web of Science ®Google Scholar
• Cohen JC. 2003. Endothelial lipase: direct evidence for a role in HDL metabolism. J Clin Invest 111:318–321.
   PubMed Web of Science ®Google Scholar
• Davidson JE, Lockhart A, Amos L, Stirnadel-Farrant HA, Mooser V, Sollberger M, et al. 2012. Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study. Alzheimers Res Ther 4:51–58.
   PubMed Web of Science ®Google Scholar
• de Havenon A, Majersik JJ, Tirschwell DL, McNally JS, Stoddard G, Rost NS. 2019. Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics. Neurology. 92:e1168–e1e75.
   PubMed Web of Science ®Google Scholar
• Ederle J, Davagnanam I, van der Worp HB, Venables GS, Lyrer PA, Featherstone RL, et al. 2013. Effect of white-matter lesions on the risk of periprocedural stroke after carotid artery stenting versus endarterectomy in the International carotid stenting study (ICSS): a prespecified analysis of data from a randomised trial. Lancet Neurol 12:866–872.
   PubMed Web of Science ®Google Scholar
• Gatz M, Reynolds CA, Finkel D, Pedersen NL, Walters E. 2010. Dementia in Swedish twins: predicting incident cases. Behav Genet 40:768–775.
   PubMed Web of Science ®Google Scholar
• Goldberg CJ, Fogarty EE, Moore DP, Dowling FE. 1997. Fluctuating asymmetry and vertebral malformation. A study of palmar dermatoglyphics in congenital spinal deformities. Spine. 22:775–779. (Phila Pa 1976).
   PubMed Web of Science ®Google Scholar
• Graff-Radford J, Arenaza-Urquijo EM, Knopman DS, Schwarz CG, Brown RD, Rabinstein AA, et al. 2019. White matter hyperintensities: relationship to amyloid and tau burden. Brain. 142:2483–2491.
   PubMed Web of Science ®Google Scholar
• Guevarra AC, Ng SC, Saffari SE, Wong BYX, Chander RJ, Ng KP, et al. 2020. Age moderates Associations of hypertension, White matter hyperintensities, and cognition. J Alzheimer's Dis 75:1351–1360.
   PubMed Web of Science ®Google Scholar
• Hainsworth AH, Minett T, Andoh J, Forster G, Bhide I, Barrick TR, et al. 2017. Neuropathology of White matter lesions, blood-brain barrier dysfunction, and dementia. Stroke. 48:2799–2804.
   PubMed Web of Science ®Google Scholar
• Han L, Zhong C, Bu X, Xu T, Wang A, Peng Y, et al. 2017. Prognostic value of lipoprotein-associated phospholipase A2 mass for all-cause mortality and vascular events within one year after acute ischemic stroke. Atherosclerosis. 266:1–7.
   PubMed Web of Science ®Google Scholar
• Hu HY, Ou YN, Shen XN, Qu Y, Ma YH, Wang ZT, et al. 2021. White matter hyperintensities and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 36 prospective studies. Neurosci Biobehav Rev 120:16–27.
   PubMed Web of Science ®Google Scholar
• Huang F, Wang K, Shen J. 2020. Lipoprotein-associated phospholipase A2: The story continues. Med Res Rev 40:79–134.
   PubMed Web of Science ®Google Scholar
• Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM. 1999. Total homocysteine and cognitive decline in a community-based sample of elderly subjects: the rotterdam study. Am J Epidemiol 150:283–289.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim H, Roh H, Kwon Y. 2018. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharmacal Res 41:372–383.
   PubMed Web of Science ®Google Scholar
• Kim M, Yoo HJ, Lee D, Lee JH. 2020. Oxidized LDL induces procoagulant profiles by increasing lysophosphatidylcholine levels, lysophosphatidylethanolamine levels, and Lp-PLA2 activity in borderline hypercholesterolemia. Nutr Metab Cardiovasc Dis 30:1137–1146.
   PubMed Web of Science ®Google Scholar
• King E, O'Brien JT, Donaghy P, Morris C, Barnett N, Olsen K, et al. 2018. Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias. J Neur Neurosurg Psychiatry 89:339–345.
   PubMed Web of Science ®Google Scholar
• Lampe L, Kharabian-Masouleh S, Kynast J, Arelin K, Steele CJ, Loffler M, et al. 2019. Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly. J Cereb Blood Flow Metab 39:36–43.
   PubMed Web of Science ®Google Scholar
• Lee S, Viqar F, Zimmerman ME, Narkhede A, Tosto G, Benzinger TL, et al. 2016. White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network. Ann Neurol 79:929–939.
   PubMed Web of Science ®Google Scholar
• Lin J, Zheng H, Cucchiara BL, Li J, Zhao X, Liang X, et al. 2015. Association of Lp-PLA2-A and early recurrence of vascular events after TIA and minor stroke. Neurology. 85:1585–1591.
   PubMed Web of Science ®Google Scholar
• Lovden M, Fratiglioni L, Glymour MM, Lindenberger U, Tucker-Drob EM. 2020. Education and cognitive functioning across the life span. Psychol Sci Public Interest 21:6–41.
   PubMed Web of Science ®Google Scholar
• Lum H, Qiao J, Walter RJ, Huang F, Subbaiah PV, Kim KS, et al. 2003. Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells. Am J Physiol Heart Circ Physiol 285:H1786–9.
   PubMed Web of Science ®Google Scholar
• Maher-Edwards G, De'Ath J, Barnett C, Lavrov A, Lockhart A. 2015. A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease. Alzheimer's Dementia: Transl Res Clin Interventions. 1:131–140.
   PubMedGoogle Scholar
• McConnell JP, Hoefner DM. 2006. Lipoprotein-associated phospholipase A2. Clin Lab Med 26:679–697. vii.
   PubMed Web of Science ®Google Scholar
• Merino JG. 2019. White matter hyperintensities on magnetic resonance imaging: What is a clinician to do? Mayo Clin Proc 94:380–382.
   PubMed Web of Science ®Google Scholar
• Mielke MM, Montine T, Khachaturian AS. 2012. Vascular diseases: one pathway toward new conceptual models of dementia. Alzheimers Dement. 8:S69–S70.
   PubMedGoogle Scholar
• Miller JW, Green R, Ramos MI, Allen LH, Mungas DM, Jagust WJ, et al. 2003. Homocysteine and cognitive function in the Sacramento Area Latino Study on aging. Am J Clin Nutr 78:441–447.
   PubMed Web of Science ®Google Scholar
• Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. 2005. The Montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699.
   PubMed Web of Science ®Google Scholar
• Nolze-Charron G, Mouiha A, Duchesne S, Bocti C. 2015. Alzheimer's Disease Neuroimaging I. White matter hyperintensities in mild cognitive impairment and lower risk of cognitive decline. J Alzheimer's Dis 46:855–862.
   PubMedGoogle Scholar
• Petersen RC. 2004. Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–194.
   PubMed Web of Science ®Google Scholar
• Pokharel Y, Mouhanna F, Nambi V, Virani SS, Hoogeveen R, Alonso A, et al. 2019. Apob, small-dense LDL-C, Lp(a), LpPLA2 activity, and cognitive change. Neurology. 92:e2580–e2e93.
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, Muscari A, Sacchetti L, Arnone G, et al. 2003. Homocysteine and cognitive function in healthy elderly community dwellers in Italy. Am J Clin Nutr 77:668–673.
   PubMed Web of Science ®Google Scholar
• Ravaglia G, Forti P, Maioli F, Zanardi V, Dalmonte E, Grossi G, et al. 2000. Blood homocysteine and vitamin B levels are not associated with cognitive skills in healthy normally ageing subjects. J Nutr Health Aging. 4:218–222.
   PubMedGoogle Scholar
• Roberts RO, Knopman DS, Przybelski SA, Mielke MM, Kantarci K, Preboske GM, et al. 2014. Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology. 82:1132–1141.
   PubMed Web of Science ®Google Scholar
• Singh-Manoux A, Dugravot A, Brunner E, Kumari M, Shipley M, Elbaz A, et al. 2014. Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife. Neurology. 83:486–493.
   PubMed Web of Science ®Google Scholar
• Smith AD, Refsum H, Bottiglieri T, Fenech M, Hooshmand B, McCaddon A, et al. 2018. Homocysteine and dementia: An International consensus statement. J Alzheimer's Dis 62:561–570.
   PubMed Web of Science ®Google Scholar
• Smith EE, Beaudin AE. 2018. New insights into cerebral small vessel disease and vascular cognitive impairment from MRI. Curr Opin Neurol 31:36–43.
   PubMed Web of Science ®Google Scholar
• Stewart CR, Stringer MS, Shi Y, Thrippleton MJ, Wardlaw JM. 2021. Associations between White matter hyperintensity burden, cerebral blood flow and transit time in small vessel disease: An updated meta-analysis. Front Neurol 12:1–19.
   Web of Science ®Google Scholar
• Strain WD, Paldanius PM. 2018. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol 17:1–10.
   PubMedGoogle Scholar
• Swardfager W, Yu D, Ramirez J, Cogo-Moreira H, Szilagyi G, Holmes MF, et al. 2017. Peripheral inflammatory markers indicate microstructural damage within periventricular white matter hyperintensities in Alzheimer's disease: A preliminary report. Alzheimer's Dementia: Diagnosis, Assessment Dis Monit 7:56–60.
   PubMedGoogle Scholar
• Tamura Y, Araki A. 2015. Diabetes mellitus and white matter hyperintensity. Geriatr Gerontol Int 15(Suppl 1):34–42.
   PubMedGoogle Scholar
• Teunissen CE, van Boxtel MP, Bosma H, Bosmans E, Delanghe J, De Bruijn C, et al. 2003. Inflammation markers in relation to cognition in a healthy aging population. J Neuroimmunol 134:142–150.
   PubMed Web of Science ®Google Scholar
• Tozer DJ, Zeestraten E, Lawrence AJ, Barrick TR, Markus HS. 2018. Texture analysis of T1-weighted and fluid-attenuated inversion recovery images detects abnormalities that correlate With cognitive decline in small vessel disease. Stroke. 49:1656–1661.
   PubMed Web of Science ®Google Scholar
• Tsimikas S, Tsironis LD, Tselepis AD. 2007. New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler, Thromb, Vasc Biol 27:2094–2099.
   PubMed Web of Science ®Google Scholar
• Tsironis LD, Mitsios JV, Milionis HJ, Elisaf M, Tselepis AD. 2004. Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase. Cardiovasc Res 63:130–138.
   PubMed Web of Science ®Google Scholar
• Tu WJ, Liu H, Liu Q, Cao JL, Guo M. 2017. Association between serum lipoprotein(a) and diabetic retinopathy in Han Chinese patients With type 2 diabetes. J Clin Endocrinol Metab 102:2525–2532.
   PubMed Web of Science ®Google Scholar
• van den Berg E, Geerlings MI, Biessels GJ, Nederkoorn PJ, Kloppenborg RP. 2018. White matter hyperintensities and cognition in Mild cognitive impairment and Alzheimer's disease: A domain-specific meta-analysis. J Alzheimer's Dis 63:515–527.
   PubMed Web of Science ®Google Scholar
• van Dijk JM, Willinsky RA. 2003. Venous congestive encephalopathy related to cranial dural arteriovenous fistulas. Neuroimaging Clin N Am 13:55–72.
   PubMed Web of Science ®Google Scholar
• Venkatesan P, Balakrishnan R, Ramadoss K, Iyer RS. 2014. Heart appearance sign in pontine stroke: a result of bilateral infarction due to small vessel disease. Neurol India 62:115–116.
   PubMedGoogle Scholar
• Vipin A, Foo HJL, Lim JKW, Chander RJ, Yong TT, Ng ASL, et al. 2018. Regional white matter hyperintensity influences grey matter atrophy in mild cognitive impairment. J Alzheimer's Dis 66:533–549.
   PubMed Web of Science ®Google Scholar
• Wang D, Guo X, Hou L, Cheng X, You T, Li H, et al. 2019. Measuring lipoprotein-associated phospholipase A2 activity in China: protocol comparison and recalibration. J Clin Lab Anal 33:1–13.
   Web of Science ®Google Scholar
• Wardlaw JM, Valdes Hernandez MC, Munoz-Maniega S. 2015. What are white matter hyperintensities made of? relevance to vascular cognitive impairment. J Am Heart Assoc 4:1–32.
   Web of Science ®Google Scholar
• Wilensky RL, Macphee CH. 2009. Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20:415–420.
   PubMed Web of Science ®Google Scholar
• Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al. 2004. Mild cognitive impairment–beyond controversies, towards a consensus: report of the International working group on Mild cognitive impairment. J Intern Med 256:240–246.
   PubMed Web of Science ®Google Scholar
• Zhang F, Guo J, Yang F, Zhou Y. 2021. Lp-PLA2 evaluates the severity of carotid artery stenosis and predicts the occurrence of cerebrovascular events in high stroke-risk populations. J Clin Lab Anal. 35:1–12.
   Web of Science ®Google Scholar
• Zhang H, Zhang JY, Sun TW, Shen DL, He F, Dang YH, et al. 2013. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2. Clin Invest Med 36:32–41.
   Web of Science ®Google Scholar
• Zhang Q, Rao P, Zhang G. 2018. Correlation between serum lipoprotein associated phosphatase A2 and vascular dementia induced by ischemic stroke. Nat Med J China. 15:1171–1175.
   Google Scholar